Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 μmol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique

Rocklage, 1989, Manganese (II) N,N′-Dipyridoxylethylenediamine-N,N′-diacetate 5,5′-bis(phosphate), 28, 477

Elizondo, 1991, Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging, Radiology, 178, 73, 10.1148/radiology.178.1.1898538

Lim, 1991, Hepatobiliary MR imaging: first human experience with MnDPDP, Radiology, 178, 79, 10.1148/radiology.178.1.1898539

Rummeny, 1991, Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors, 26, S142

Bernardino, 1992, Hepatic MR imaging with MnDPDP: safety, image quality and sensitivity, Radiology, 183, 53, 10.1148/radiology.183.1.1549694

Rofsky, 1992, Manganese (II), N,N′-Dipiridoxylethylenediamine-N,N′-diacetate 5,5′-bis(phosphate): clinical experience with a new contrast agent, Magn Reson Q, 8, 156

Grant, 1994, Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy, Invest Radiol, 29, S249, 10.1097/00004424-199406001-00085

Gehl, 1991, Pancreatic enhancement after low-dose infusion of MnDPDP, Radiology, 180, 337, 10.1148/radiology.180.2.1906189

Gehl, 1993, MnDPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience, Radiology, 186, 795, 10.1148/radiology.186.3.8430190

Hamm, 1992, Focal liver lesions: MR imaging with MnDPDP, 182, 167

Vogl, 1993, MnDPDP enhancement patterns of hepatocellular lesions on MR Images, J Magn Reson Imaging, 3, 51, 10.1002/jmri.1880030110

Marchal, 1993, MnDPDP enhanced MRI in experimental bile duct obstruction, J Comput Assisted Tomogr, 17, 290, 10.1097/00004728-199303000-00021

Aicher, 1993, MnDPDP-enhanced MR Imaging of malignant liver lesions: Efficacy and Safety in 20 patients, J Magn Reson Imaging, 3, 731, 10.1002/jmri.1880030507

Misselwitz, 1995, A toxicologic risk for using manganese complexes?, 10, 611

Birnbaum, 1994, Comparison of contrast-enhanced CT and MnDPDP enhanced MRI for detection of focal hepatic lesions, Initial findings. Clin Imaging, 18, 21, 10.1016/0899-7071(94)90141-4

Heiken, 1989, Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography and MR Imaging, Radiology, 171, 47, 10.1148/radiology.171.1.2538862

Nelson, 1989, Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR Imaging for preoperative evaluation, Radiology, 172, 27, 10.1148/radiology.172.1.2662254

Rummeny, 1995, Detection and characterization of focal liver lesions before and after administration of MnDPDP: results of an independent image evaluation in 300 patients, Radiology RSNA, 197 (P, 415

Ni, 1993, Experimental liver cancers: MnDPDP-enhanced rims in MR, 188, 45

Rofsky, 1993, Hepatocellular tumors: characterization with MnDPDP-enhanced MR imaging, Radiology, 188, 53, 10.1148/radiology.188.1.8390072

Murakami, 1996, Cirrhosis of the liver: MR Imaging with mangafodipir trisodium (MnDPDP), Radiology, 198, 567, 10.1148/radiology.198.2.8596867

Ni, 1993, The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats, 28, 520